Calidi Biotherapeutics CLDI
NYSE CLDI
$1.34 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

Calidi Biotherapeutics (CLDI) Property, Plant & Equipment (Net) (2024 - 2026)

Calidi Biotherapeutics (CLDI) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Calidi Biotherapeutics 1.88 Mn -2.22 Mn - 775,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 775,000.00
Jun 30, 2026 775,000.00
Dec 31, 2025 781,000.00
Dec 31, 2025 781,000.00
Sep 30, 2025 849,000.00
Sep 30, 2025 849,000.00
Jun 30, 2025 929,000.00
Jun 30, 2025 929,000.00
Mar 31, 2025 795,000.00
Mar 31, 2025 795,000.00
Dec 31, 2024 869,000.00
Dec 31, 2024 869,000.00